Cargando…
The issue of plasma asymmetric dimethylarginine reference range – A systematic review and meta-analysis
BACKGROUND: Asymmetric dimethylarginine (ADMA) is an endogenous inhibitor of nitric oxide synthase, marker and mediator of endothelial dysfunction. Several studies have demonstrated its value in cardiovascular risk stratification and all-cause mortality prediction. The aim was to determine the refer...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5426758/ https://www.ncbi.nlm.nih.gov/pubmed/28494019 http://dx.doi.org/10.1371/journal.pone.0177493 |